What does BRAIDWELL LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Comprehensive Analysis of BRAIDWELL LP SEC 13F Filing

Portfolio Overview

Braidwell LP manages a concentrated, high-conviction portfolio with a distinct focus on the healthcare and biotechnology sectors. As of the report date September 30, 2025, the firm reported total assets under management (AUM) of approximately $2.04 billion across 47 holdings. This represents a significant reduction in portfolio value, decreasing by 30.2% from the previous quarter's $2.92 billion. The decline in AUM i...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

CAI

CARIS LIFE SCIENCES INC

$143M8.0M4.8%

GH 1.25 02/15/31

GUARDANT HEALTH INC

$103M61.0M3.4%

RGEN 1 12/15/28

REPLIGEN CORP

$99M101.0M3.3%

NEO 0.25 01/15/28

NEOGENOMICS INC

$92M100.4M3.1%

NBIX

NEUROCRINE BIOSCIENCES INC

$86M652K2.9%

GKOS

GLAUKOS CORP

$82M764K2.7%

CNTA

CENTESSA PHARMACEUTICALS PLC

$79M2.0M2.6%

XENE

XENON PHARMACEUTICALS INC

$78M1.3M2.6%

DNTH

DIANTHUS THERAPEUTICS INC

$75M899K2.5%

EWTX

EDGEWISE THERAPEUTICS INC

$74M2.3M2.5%

Filing history

Filing history loading…